Jan 09, 2023 / 09:30PM GMT
David A. Low - JPMorgan Chase & Co, Research Division - Research Analyst
Music has gone off. So that's my queue. Afternoon, everyone. Welcome back to the afternoon sessions. My name is David Low. I cover health care out of Sydney for JPMorgan. With us this afternoon, we have ResMed, CEO, Mick Farrell. So Mick is going to present for about 20 minutes, and then we'll do 20 minutes of Q&A. A quick reminder, there is the digital conference book if you'd like to ask questions online, but there will also be a mic and it's probably easy to use the mic if you're in the room. Over to you, Mick.
Michael J. Farrell - ResMed Inc. - CEO & Director
Great. Well, thanks, David, and good afternoon all. Go through the disclaimers there from our legal team. So what's ResMed? ResMed is aimed -- ResMed stands for respiratory medicine, but ResMed also stands for residential medicine, treatment and care, where you live and preferably in your own home. And our total addressable market includes our core market of sleep suffocation, as I call it, or sleep apnea as the
Resmed Inc at JPMorgan Healthcare Conference Transcript
Jan 23, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers